Literature DB >> 12772705

Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma?

R H Oyen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12772705     DOI： 10.1007/s00330-003-1850-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  18 in total

1.  In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland.

Authors:  G P Liney; L W Turnbull; A J Knowles
Journal:  NMR Biomed       Date:  1999-02       Impact factor: 4.044

2.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results.

Authors:  François Cornud; Thierry Flam; Laurent Chauveinc; Khaled Hamida; Yves Chrétien; Annick Vieillefond; Olivier Hélénon; Jean François Moreau
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

3.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

4.  Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer.

Authors:  K Engelhard; H P Hollenbach; M Deimling; M Kreckel; C Riedl
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

5.  [Prostate and prostatic carcinoma: comparison of gadolinium-enhanced MR images and histopathologic findings].

Authors:  T Yoshizako; K Sugimura; Y Kaji; M Moriyama; A Wada
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1995-07

6.  Prostate cancer staging: should MR imaging be used?--A decision analytic approach.

Authors:  G J Jager; J L Severens; J R Thornbury; J J de La Rosette; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

7.  The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients.

Authors:  J C Vilanova; J Comet; A Capdevila; J Barceló; J L Dolz; M Huguet; C Barceló; J Aldomà; E Delgado
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

8.  Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast-enhancement in patients with localized prostate cancer: mapping studies with biopsy specimens.

Authors:  N Tanaka; S Samma; M Joko; T Akiyama; M Takewa; S Kitano; E Okajima
Journal:  Int J Urol       Date:  1999-12       Impact factor: 3.369

9.  The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma.

Authors:  G Brown; D A Macvicar; V Ayton; J E Husband
Journal:  Clin Radiol       Date:  1995-09       Impact factor: 2.350

10.  Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.

Authors:  C Frouge; J M Guinebretière; G Contesso; R Di Paola; M Bléry
Journal:  Invest Radiol       Date:  1994-12       Impact factor: 6.016
View more
  6 in total

1.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Authors:  B Nicolas Bloch; Elizabeth M Genega; Daniel N Costa; Ivan Pedrosa; Martin P Smith; Herbert Y Kressel; Long Ngo; Martin G Sanda; William C Dewolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

2.  Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT.

Authors:  Anke M Hövels; Roel A M Heesakkers; Eddy M Adang; Gerrit J Jager; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

Review 3.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

4.  Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil.

Authors:  J R Haaga; A Exner; B Fei; A Seftel
Journal:  Int J Impot Res       Date:  2006-05-25       Impact factor: 2.896

5.  MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.

Authors:  Cynthia Ménard; Robert C Susil; Peter Choyke; Gary S Gustafson; William Kammerer; Holly Ning; Robert W Miller; Karen L Ullman; Nancy Sears Crouse; Sharon Smith; Etienne Lessard; Jean Pouliot; Victor Wright; Elliot McVeigh; C Norman Coleman; Kevin Camphausen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

Review 6.  Multidisciplinary functional MR imaging for prostate cancer.

Authors:  Jeong Kon Kim; Yun-Jin Jang; Gyunggoo Cho
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.